NCT04219800

Brief Summary

Type 2 diabetes mellitus (T2DM) patients are suboptimal treated due to low uptake of physical activity. Recent research shows promising beneficial health effects from reducing sitting time by regular short bouts of light-intensity physical activity. These findings open up for a new focus in T2DM treatment but conclusive evidence is missing as studies have been short-term trials, mainly conducted in laboratory environments. Recent research suggest that reduced sitting and increased physical activity can be supported at a low cost by mHealth (mobile health) technology such as activity tracker armbands that warns of prolonged sitting and SMS text messages that reminds of activity breaks. The overarching purpose of the project is to evaluate the effects of an intervention aimed to reduce occupational sitting in T2DM using mHealth (mobile health). It is hypothesized that the intervention will lead to (1) Activity changes - reduced sitting time and/or increased number of steps (primary outcome measures) and (2) Health effects - lower fatigue, improved health-related quality of life, reduced cardiometabolic risk, less sick leave, less medication, less musculoskeletal problems (secondary outcome measures)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
142

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Dec 2020

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 7, 2020

Completed
11 months until next milestone

Study Start

First participant enrolled

December 8, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

January 18, 2024

Status Verified

January 1, 2024

Enrollment Period

3.1 years

First QC Date

January 2, 2020

Last Update Submit

January 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sitting time

    Assessed by activPAL3 thigh-worn accelerometer

    12 months

Secondary Outcomes (7)

  • Steps

    12 months

  • Fatigue

    12 months

  • Health-related quality of life

    12 months

  • Cardiometabolic composite score (CCMR)

    12 months

  • Sick leave

    12 months

  • +2 more secondary outcomes

Other Outcomes (1)

  • General self-efficacy

    12 months

Study Arms (2)

mHealth

EXPERIMENTAL

1. Activity tracker armband (Garmin Vivofit); warns of prolonged sitting and counts daily steps. 2. SMS text messages; reminds of activity breaks. 3. Mobile video instruction for standing pause gymnastics.

Behavioral: Patient-centered counselling and written materialBehavioral: mHealth

Control

OTHER

Patient-centered counselling and written material regarding occupational sedentary behaviour, with telephone follow-ups after 1 and 5 weeks.

Behavioral: Patient-centered counselling and written material

Interventions

Patient-centered counselling and written material regarding occupational sedentary behaviour, with telephone follow-ups after 1 and 5 weeks.

ControlmHealth
mHealthBEHAVIORAL

1. Activity tracker armband (Garmin Vivofit); warns of prolonged sitting and counts daily steps. 2. SMS text messages; reminds of activity breaks. 3. Mobile video instruction for standing pause gymnastics.

mHealth

Eligibility Criteria

Age40 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Type 2 Diabetes Melltitus
  • years
  • HbA1c 48-100 mmol/mol
  • BMI ≥ 25 kg/m2
  • Working at least 75% of full-time in a mainly seated job.

You may not qualify if:

  • Pregnancy
  • Regular vigorous intensity exercise
  • Severe disease or for other reason unable to follow the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Björkskatans Hälsocentral

Luleå, Norrbotten County, Sweden

Location

Hallsbergs hälsocentral

Hallsberg, Sweden

Location

Kärna Vårdcentral

Linköping, Sweden

Location

Clinical Research Centre

Östersund, Sweden

Location

Torsviks Vårdcentral

Stockholm, Sweden

Location

Clinical Research Centre

Umeå, Sweden

Location

Related Publications (1)

  • Syrjala MB, Bennet L, Dempsey PC, Fharm E, Hellgren M, Jansson S, Nilsson S, Nordendahl M, Rolandsson O, Radholm K, Ugarph-Morawski A, Wandell P, Wennberg P. Health effects of reduced occupational sedentary behaviour in type 2 diabetes using a mobile health intervention: a study protocol for a 12-month randomized controlled trial-the ROSEBUD study. Trials. 2022 Jul 27;23(1):607. doi: 10.1186/s13063-022-06528-x.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Telemedicine

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Patrik Wennberg

    Umeå University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

January 2, 2020

First Posted

January 7, 2020

Study Start

December 8, 2020

Primary Completion

December 30, 2023

Study Completion

December 30, 2024

Last Updated

January 18, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations